Philip Bonomi
Philip Bonomi publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #833,734 of 7,710,434 ranked researchers
- Rank in United States
- #277,143 of 1,627,098
- Works
- 402
- Citations
- 12k
- Citations per work
- 30.1
What does Philip Bonomi research?
Philip Bonomi's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences26766.5%
- Medicine26766.5%
- Everything else8320.7%
- Life Sciences5112.8%
- 1Pulmonary and Respiratory Medicine32% of their works
- 2Oncology27% of their works
- 3Molecular Biology9% of their works
- 4Cancer Research4% of their works
- 5Physiology4% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
Which keywords describe Philip Bonomi's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Metastasis, Genomic Profiles and Small-Cell Lung Cancer.
- Immunity
- KRAS Mutations
- Taxanes
- Sarcopenia
- PD-1 and PD-L1
- Inflammation
- Lung Cancer
- Small-Cell Lung Cancer
- Metastasis
- ALK Inhibitors
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- EGFR Mutations
- Genomic Profiles
- CT Screening
- Tumor Microenvironment
- Immune Checkpoint Blockade
- Cancer Cachexia
- Chemotherapy-Induced Peripheral Neuropathy
- Cetuximab
- Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Clinical Trials2992 topics
- Targeted Therapy2992 topics
- Chemotherapy2313 topics
- ALK Inhibitors1921 topic
- EGFR Mutations1921 topic
- Metastasis1282 topics
- Genomic Profiles1071 topic
- Small-Cell Lung Cancer1071 topic
- CT Screening1021 topic
- Lung Cancer1021 topic
- Tumor Microenvironment712 topics
- Inflammation542 topics
- Immune Checkpoint Blockade501 topic
- PD-1 and PD-L1501 topic
- Cancer Cachexia331 topic
- Sarcopenia331 topic
- Chemotherapy-Induced Peripheral Neuropathy251 topic
- Taxanes251 topic
- Cetuximab221 topic
- KRAS Mutations221 topic
- Cancer211 topic
- Immunity211 topic
Where does Philip Bonomi work?
Philip Bonomi's main affiliation in the publication record is Rush University Medical Center, United States.
How many publications and citations does Philip Bonomi have?
OpenAlex counts 402 works and 12,082 citations for Philip Bonomi, an h-index of 48, ranking #833,734 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Philip Bonomi
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Philip Bonomi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.